T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Vita Coco
COCO
$3.77B
| $367K | ﹤0.01% |
12,946
+459
| +4% | +$12.2K |
|
|
AAN
2377
DELISTED
The Aaron's Company Inc
AAN
| $365K | ﹤0.01% |
36,650
+131
| +0.4% | +$1.31K |
|
2378
Transcat
TRNS
$888M
| $364K | ﹤0.01% |
3,008
+261
| +10% | +$32.4K |
|
2379
ANI Pharmaceuticals
ANIP
$1.72B
| $363K | ﹤0.01% |
6,068
+186
| +3% | +$11.3K |
|
2380
Phibro Animal Health
PAHC
$1.38B
| $363K | ﹤0.01% |
16,103
+179
| +1% | +$3.46K |
|
2381
PubMatic
PUBM
$787M
| $363K | ﹤0.01% |
24,378
+915
| +4% | +$15.9K |
|
2382
Build-A-Bear
BBW
$474M
| $362K | ﹤0.01% |
10,506
+113
| +1% | +$3.18K |
|
2383
Primis Financial Corp
FRST
$413M
| $361K | ﹤0.01% |
29,563
-7,430
| -20% | -$87.7K |
|
|
ZIMV
2384
DELISTED
ZimVie
ZIMV
| $361K | ﹤0.01% |
22,719
| – | – |
|
2385
Lightwave Logic
LWLG
$1.12B
| $360K | ﹤0.01% |
130,335
+31,516
| +32% | +$94.6K |
|
2386
Schneider National
SNDR
$6.37B
| $360K | ﹤0.01% |
12,592
+1,284
| +11% | +$33.9K |
|
2387
Vera Bradley
VRA
$94.7M
| $360K | ﹤0.01% |
65,874
+8,673
| +15% | +$51.2K |
|
2388
American Vanguard Corp
AVD
$62.8M
| $359K | ﹤0.01% |
67,688
+16,300
| +32% | +$115K |
|
2389
Anavex Life Sciences
AVXL
$303M
| $359K | ﹤0.01% |
63,109
+9,314
| +17% | +$53.7K |
|
|
VTLE
2390
DELISTED
Vital Energy
VTLE
| $358K | ﹤0.01% |
13,282
+288
| +2% | +$10.7K |
|
2391
Pulmonx
LUNG
$92.8M
| $357K | ﹤0.01% |
43,008
+299
| +0.7% | +$2.16K |
|
2392
TeraWulf
WULF
$8.14B
| $357K | ﹤0.01% |
76,106
+2,884
| +4% | +$13.1K |
|
2393
FuboTV Inc
FUBO
$296M
| $356K | ﹤0.01% |
20,840
+611
| +3% | +$11K |
|
|
RAPT
2394
DELISTED
RAPT Therapeutics
RAPT
| $355K | ﹤0.01% |
21,972
-4,090
| -16% | -$82.7K |
|
2395
Covenant Logistics
CVLG
$880M
| $354K | ﹤0.01% |
13,394
+480
| +4% | +$12.4K |
|
|
CMRC
2396
Commerce.com Inc Series 1
CMRC
$184M
| $352K | ﹤0.01% |
60,067
| – | – |
|
2397
Pure Cycle
PCYO
$273M
| $350K | ﹤0.01% |
32,454
-4,136
| -11% | -$42.4K |
|
2398
Enact Holdings
ACT
$6.84B
| $349K | ﹤0.01% |
9,579
+346
| +4% | +$11.8K |
|
2399
Cerus
CERS
$572M
| $348K | ﹤0.01% |
199,583
+1,270
| +0.6% | +$2.67K |
|
|
SEI
2400
Solaris Energy Infrastructure
SEI
$3.94B
| $347K | ﹤0.01% |
27,182
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.